Climb Bio, Inc.

CLYM chart

Climb Bio, Inc. news

• Freedom Broker raises Climb Bio stock price target on trial data progress

  Investing.com · Nov 10, 12:56 PM EST

• Form 13D/A Climb Bio For: 9 November By Investing.com

  Investing.com Canada · Nov 9, 9:25 PM EST

• Climb Bio at Guggenheim healthcare conference: pipeline nears pivotal tests

  Investing.com · Nov 9, 4:33 PM EST

• H.C. Wainwright Maintains Climb Bio(CLYM.US) With Buy Rating, Maintains Target Price $30

  Moomoo · Nov 9, 8:47 AM EST

• Wedbush Maintains Climb Bio(CLYM.US) With Buy Rating, Raises Target Price to $27

  Moomoo · Nov 7, 12:48 PM EST

• Climb Bio, Inc. (CLYM) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 7, 6:56 AM EST

• Wedbush keeps Climb Bio on Best Ideas List, raises price target

  Yahoo Finance · Nov 6, 11:58 AM EST

• Oppenheimer reiterates Climb Bio stock rating on SLE data

  Investing.com · Nov 6, 7:14 AM EST

• Baird reiterates Climb Bio stock rating on clinical progress

  Investing.com · Nov 5, 1:29 PM EST

• Wedbush raises Climb Bio stock price target on drug pipeline By Investing.com

  Investing.com Nigeria · Nov 5, 10:09 AM EST

• Raymond James reiterates Strong Buy on Climb Bio stock, $34 target

  Investing.com · Nov 5, 9:42 AM EST

• Wedbush raises Climb Bio stock price target on drug pipeline

  Investing.com · Nov 5, 9:42 AM EST

Climb Bio, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-05
• 8-K8-K2026-11-05
• 8-K8-K2026-10-26
• 8-K8-K2026-10-23
• 8-K8-K2026-09-03
• 8-K8-K2026-08-14
• 10-Q10-Q2026-08-06
• 8-K8-K2026-08-06
• 8-K8-K2026-07-01
• 8-K8-K2026-06-12
• 8-K8-K2026-06-11
• 8-K8-K2026-06-08

About Climb Bio, Inc.

Ticker

CLYM (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Wellesley Hills, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1768446

Former names

Eliem Therapeutics, Inc.

Frequently asked questions